- Home
- BYD vs LEGN Comparison
BYD vs LEGN Comparison
Compare BYD & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYD | LEGN |
|---|---|---|
| Founded | 1973 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.9B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BYD | LEGN |
|---|---|---|
| Price | $82.76 | $20.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $90.91 | $63.46 |
| AVG Volume (30 Days) | 852.7K | ★ 1.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | ★ 264.46 | N/A |
| EPS | ★ 22.56 | N/A |
| Revenue | ★ $2,626,730,000.00 | N/A |
| Revenue This Year | $2.13 | $46.27 |
| Revenue Next Year | $2.66 | $28.77 |
| P/E Ratio | $3.57 | ★ N/A |
| Revenue Growth | ★ 9.41 | N/A |
| 52 Week Low | $58.94 | $16.24 |
| 52 Week High | $89.96 | $45.30 |
Technical Indicators
Market Signals| Indicator | BYD | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.23 | 60.43 |
| Support Level | $79.81 | $16.24 |
| Resistance Level | $86.18 | $21.58 |
| Average True Range (ATR) | 2.49 | 0.91 |
| MACD | -0.25 | 0.25 |
| Stochastic Oscillator | 50.27 | 68.20 |
Price Performance
Historical ComparisonAbout BYD Boyd Gaming Corporation
Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.